pancrelipase

FDA Drug Profile — PERTZYE

Drug Details

Generic Name
pancrelipase
Brand Names
PERTZYE
Application Number
BLA022175
Sponsor
Digestive Care, Inc.
NDC Codes
4
Dosage Forms
CAPSULE, DELAYED RELEASE
Routes
ORAL
Active Ingredients
PANCRELIPASE AMYLASE, PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE

Indications and Usage

1. INDICATIONS AND USAGE VIOKACE, in combination with a proton pump inhibitor, is indicated for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy in adults. VIOKACE, in combination with a proton pump inhibitor, is indicated for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy in adults. ( 1 )